In recent trading session, Hims & Hers Health Inc (NYSE:HIMS) saw 15.25 million shares changing hands at last check today with its beta currently measuring 1.42. Company’s recent per share price level of $62.87 trading at -$5.87 or -8.54% at last check today assigns it a market valuation of $13.74B. That most recent trading price of HIMS’s stock is at a discount of -16.08% from its 52-week high price of $72.98 and is indicating a premium of 85.33% from its 52-week low price of $9.22.
For Hims & Hers Health Inc (HIMS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.38. Splitting up the data highlights that, out of 13 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 5 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.21 in the current quarter.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Upright in the red during last session for losing -8.54%, in the last five days HIMS remained trading in the green while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $62.87 price level, adding 13.85% to its value on the day. Hims & Hers Health Inc’s shares saw a change of 160.01% in year-to-date performance and have moved 35.67% in past 5-day. Hims & Hers Health Inc (NYSE:HIMS) showed a performance of 110.90% in past 30-days.
Wall Street analysts have assigned a consensus price target of 25 to the stock, which implies a fall of -151.48% to its recent value today. Analysts have been projecting 20 as a low price target for the stock while placing it at a high target of 38. It follows that stock’s current price would jump 68.19% in reaching the projected high whereas dropping to the targeted low would mean a gain of 68.19% for stock’s current value.
Hims & Hers Health Inc (HIMS) estimates and forecasts
This year revenue growth is estimated to rise 67.79% from the last financial year’s standing.
13 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 470.3M for the same. And 10 analysts are in estimates of company making revenue of 493.61M in the next quarter. Company posted 246.62M and 278.17M of sales in current and next quarters respectively a year earlier.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
VANGUARD GROUP INC is the top institutional holder at HIMS for having 16.47 million shares of worth $332.55 million. And as of 2024-06-30, it was holding 7.7166 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 14.57 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.8278 of outstanding shares, having a total worth of $294.25 million.
On the other hand, iShares Core S&P Smallcap ETF and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024, the former fund manager was holding 12.28 shares of worth $767.93 million or 5.85% of the total outstanding shares. The later fund manager was in possession of 5.33 shares on Nov 30, 2024, making its stake of worth around $333.35 million in the company or a holder of 2.54% of company’s stock.
